Bacterial genome and mutation
- General bacteriology
How bacteria store their genes (chromosome, plasmids, jumping genes) and how small DNA changes let them adapt, including to antibiotics.
What it is
A bacterium keeps its essential genes on one chromosome, usually a single circular DNA molecule, and often carries extra genes on plasmids and mobile elements. Because bacteria are haploid and divide fast in huge numbers, a rare mutation that helps survival, such as one that blocks an antibiotic, is quickly selected. Genes pass down to daughter cells (vertical inheritance) and can also move sideways between cells, which is covered in Gene transfer in bacteria.
Key facts
- Spontaneous mutations are rare per gene, but a large bacterial population almost always contains some mutants: the antibiotic selects them, it does not create them
- Mutagens such as UV light, radiation and certain chemicals raise the mutation rate; the Ames test uses Salmonella mutants to screen chemicals for mutagenicity
- Phase variation (switching a gene on and off) and antigenic variation help bacteria escape antibodies: Neisseria pili, Borrelia surface proteins
- Combination therapy for tuberculosis exists because a mutant resistant to two drugs at once is far rarer than one resistant to a single drug
- Hypermutator strains with defective DNA repair arise in chronic infections, such as Pseudomonas aeruginosa in cystic fibrosis lungs
Structure
- Chromosome: usually one circular, haploid DNA molecule in the nucleoid, with no nuclear membrane; exceptions exist (Vibrio cholerae has two chromosomes, Borrelia a linear one)
- Plasmids: small extrachromosomal DNA circles that replicate on their own; they carry extra traits such as resistance, toxins or fertility (F plasmid)
- Insertion sequences: the simplest mobile elements, carrying only the genes needed to move (a transposase)
- Transposons: jumping genes that move between chromosome, plasmid and phage DNA, often carrying resistance genes (vanA travels on a transposon)
- Integrons: gene-capture platforms with an integrase and a promoter that collect and express resistance gene cassettes; class 1 integrons are common in Gram-negative hospital bacteria
- Genomic and pathogenicity islands: large blocks of foreign DNA in the chromosome, e.g. SCCmec carrying mecA in MRSA
Step by step
- A huge, fast-dividing haploid population makes rare spontaneous mutations in every generation
- By chance a few cells carry a change in a drug target, such as rpoB (rifampicin) or gyrA (fluoroquinolones)
- The antibiotic kills the susceptible majority; the mutants that were already there survive
- The survivors multiply and become the whole population: resistance was selected, not created
- Two drugs at once would need a double mutant, which is far rarer: the reason tuberculosis is never treated with one drug
Types of mutation and clinical examples
| Mutation | What changes | Example |
|---|---|---|
| Base substitution (point) | One base swapped: silent, missense (new amino acid) or nonsense (stop codon) | rpoB point mutations give rifampicin resistance in M. tuberculosis |
| Frameshift | Insertion or deletion of bases that is not a multiple of three shifts the reading frame | Often inactivates a gene completely |
| Deletion or insertion of a block | Loss or gain of a stretch of DNA, sometimes by an insertion sequence landing in a gene | katG loss in isoniazid-resistant M. tuberculosis |
| Rearrangement | Inversion, duplication or gene conversion of DNA segments | Pilin and surface-antigen switching in Neisseria gonorrhoeae and relapsing-fever Borrelia |
| Target mutation in topoisomerase | Changes in gyrA or parC lower drug binding | Fluoroquinolone resistance in E. coli and Salmonella Typhi |
Clinical notes
- Resistance that appears during treatment of one patient usually reflects selection of chromosomal mutants (e.g. rifampicin used alone)
- Resistance that spreads quickly between species and hospitals usually travels on plasmids, transposons and integrons
- Molecular tests for drug resistance read known mutations directly, such as rpoB for rifampicin in tuberculosis
Common traps
- Antibiotics cause the mutations that make bacteria resistant: resistant mutants arise spontaneously at a low rate before any drug is given; the antibiotic only removes their susceptible neighbours.
- All antibiotic resistance comes from mutation: resistance that crosses species and hospitals usually travels on plasmids, transposons and integrons rather than arising in each strain separately.
- A plasmid is simply a small piece of the chromosome: it is a separate DNA circle that replicates on its own and can be passed to other cells, carrying extra traits such as resistance, toxins or fertility.
- A second tuberculosis drug only adds side effects: a mutant resistant to two drugs at once is far rarer than one resistant to a single drug, so the combination blocks selection of resistance.
Test yourself
Think of the answer, then tap the question to see it.
A patient with tuberculosis takes rifampicin alone for weeks, and the isolate becomes rifampicin-resistant. What happened in the bacterial population?
Rifampicin killed the susceptible bacilli and selected rpoB mutants that were already present; the drug did not create the mutation.
Carbapenem resistance appears in Klebsiella and E. coli on several wards within months. Is mutation or mobile DNA the likelier explanation, and why?
Mobile DNA: fast spread across species and wards points to resistance genes moving on plasmids, transposons or integrons, not to each strain mutating on its own.
Why can a molecular test report rifampicin resistance in tuberculosis within hours, before any culture grows?
Rifampicin resistance comes from known point mutations in rpoB, so the test reads those mutations directly in the bacterial DNA.
Why does combining drugs prevent resistance in tuberculosis when a single drug does not?
A mutant resistant to one drug is rare; one resistant to two at once is far rarer, so a population large enough to hold single mutants rarely holds a double mutant.
Why can Neisseria gonorrhoeae keep escaping the antibodies a person made against it before?
Rearrangement and gene conversion keep switching its pilin and surface antigens, so antibodies against the old version no longer recognise the new one.
Connections
Microorganisms8
In Pharmacology4
Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: Mutation (National Human Genome Research Institute (NHGRI), 2026); Plasmid (National Human Genome Research Institute (NHGRI), 2026); Antimicrobial Resistance: Causes and How It Spreads (Centers for Disease Control and Prevention (CDC), 2025); Horizontal Gene Transfer (Evolution, Medicine, and Public Health (Burmeister AR), 2015).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
